Alzheimer’s Disease Study Questions Glucosamine Safety
Key Summary New research published in Nature Metabolism suggests that abnormal brain glycosylation may contribute to Alzheimer’s disease progression. Glucosamine
Read MoreKey Summary New research published in Nature Metabolism suggests that abnormal brain glycosylation may contribute to Alzheimer’s disease progression. Glucosamine
Read MoreKey Points Summary New Alzheimer’s drugs such as donanemab and lecanemab are generating optimism but remain controversial due to modest
Read MoreKey Highlights Microglial cells in Alzheimer’s brains carry cancer-linked mutations Mutations found in genes associated with leukemia and lymphoma Blood
Read MoreKey Takeaways Brain vascular health is strongly linked to early Alzheimer’s-related brain changes. Noninvasive measures of blood flow and oxygenation
Read MoreKey Takeaways for HCPs Nanoplastics are now detected in human brain tissue and blood Evidence links a higher plastic burden
Read MoreA new narrative review in Cureus examines whether coffee truly enhances cognition, protects the brain, and supports memory. The evidence
Read MoreCreatine Supplementation Shows Promise in Alzheimer’s Care Alzheimer’s disease (AD) is widely recognized for its cognitive decline, but it also
Read MoreBreakthrough Study Highlights Brain Blood Flow Dynamics in Alzheimer’s Disease New research from USC Viterbi School of Engineering has uncovered
Read MoreAs the population ages, scientists are urgently exploring why older individuals are more susceptible to neurodegenerative diseases. A new study
Read MoreA new study published in Molecular Psychiatry has confirmed that blood-based biomarkers—particularly plasma p-tau181—can detect early signs of Alzheimer’s disease
Read More